Explore detailed financial insights for NSE: Dishman Carbogen Amcis Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Dishman Carbogen Amcis Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Dcal, including updates on board meetings and corporate actions.

DCAL
Dishman Carbogen Amcis Limited - https://imdcal.com
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Dishman Carbogen Amcis Limited Share Price Today

229.60
OPEN
233.35
HIGH
226.65
LOW
229.00
CLOSE
405 K
VOLUME
4,234 Cr
Market Cap
1381104
Average Volume
Healthcare
Sector
NSI
Exchange

Dishman Carbogen Amcis Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: DCAL Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Dishman Carbogen Amcis Limited
DCAL
INE385W01011
Dividend - Rs 0.20 Per Share
12 Sep 2019
2
N/A

NSE: DCAL Recent Announcements

Symbol
Date
Description
Industry
DCAL
01 Jan 2025, 18:41:13
Copy of Newspaper Publication
N/A
DCAL
31 Dec 2024, 18:26:56
Notice Of Shareholders Meetings-XBRL
N/A
DCAL
31 Dec 2024, 18:07:00
Shareholders meeting
N/A
DCAL
26 Dec 2024, 19:05:11
Trading Window-XBRL
N/A
DCAL
26 Dec 2024, 19:01:12
Trading Window
N/A

NSE: DCAL Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Dishman Carbogen Amcis Limited
DCAL
14 Oct 2024, 19:51:00
14 Oct 2024, 19:51:00
Dishman Carbogen Amcis Limited
DCAL
19 Jul 2024, 19:35:00
19 Jul 2024, 19:35:00
Dishman Carbogen Amcis Limited
DCAL
15 May 2024, 16:19:00
15 May 2024, 16:19:00
Dishman Carbogen Amcis Limited
DCAL
18 Jan 2024, 12:00:00
18 Jan 2024, 12:30:00
Dishman Carbogen Amcis Limited
DCAL
20 Oct 2023, 20:00:00
20 Oct 2023, 20:30:00

NSE: DCAL Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson Related To Promoters,Non-Executive Director
29 Apr 1951
01 Mar 2015
00004730
Vyas Janmejay R
Active
Executive Director
15 Oct 1951
03 Sep 2016
00004876
Deohooti Janmejay Vyas
Active
Executive Director-MD
28 Jul 1986
01 Jun 2014
01540057
Arpit Janmejay Vyas
Active
Independent Director
01 Feb 1948
02 Apr 2015
00061922
Shah Rajendra Shantilal
Active
Independent Director
18 Nov 1953
15 Dec 2014
02237356
Subir Kumar Das
Active

NSE: DCAL Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
Board Meeting Intimation
DCAL
N/A
INE385W01011
Dishman Carbogen Amcis Limited
07 Nov 2024, 21:11:47
DISHMAN CARBOGEN AMCIS LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .
DCAL
N/A
INE385W01011
Dishman Carbogen Amcis Limited
08 Aug 2024, 12:57:46
DISHMAN CARBOGEN AMCIS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Fund raising.
DCAL
N/A
INE385W01011
Dishman Carbogen Amcis Limited
24 May 2024, 20:29:04
Financial Results
DCAL
N/A
INE385W01011
Dishman Carbogen Amcis Limited
06 Feb 2024, 18:16:02
DISHMAN CARBOGEN AMCIS LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 .
DCAL
N/A
INE385W01011
Dishman Carbogen Amcis Limited
01 Nov 2023, 13:28:02

NSE: DCAL Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
DCAL
-
INE385W01011
Dishman Carbogen Amcis Limited
07 Nov 2024, 00:00:00
To consider and approve the financial results for the period ended September 30, 2024
Financial Results
DCAL
-
INE385W01011
Dishman Carbogen Amcis Limited
07 Aug 2024, 00:00:00
To consider and approve the financial results for the period ended Jun 30, 2024
Financial Results/Fund Raising
DCAL
-
INE385W01011
Dishman Carbogen Amcis Limited
24 May 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024 and Fund Raising
Financial Results
DCAL
-
INE385W01011
Dishman Carbogen Amcis Limited
06 Feb 2024, 00:00:00
To consider and approve the financial results for the period ended December 31, 2023
Financial Results
DCAL
-
INE385W01011
Dishman Carbogen Amcis Limited
01 Nov 2023, 00:00:00
To consider and approve the financial results for the period ended September 30, 2023

NSE: DCAL Balance Sheet Data In (Cr)

date period_type Treasury Shares Number Ordinary Shares Number Share Issued Net Debt Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Stockholders Equity Other Equity Interest Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Other Non Current Liabilities Tradeand Other Payables Non Current Non Current Deferred Revenue Non Current Deferred Taxes Liabilities Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Deferred Taxes Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Dividends Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Non Current Deferred Taxes Assets Investmentin Financial Assets Held To Maturity Securities Available For Sale Securities Financial Assets Designatedas Fair Value Through Profitor Loss Trading Securities Investment Properties Goodwill And Other Intangible Assets Other Intangible Assets Goodwill Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Restricted Cash Prepaid Assets Inventory Finished Goods Work In Process Raw Materials Other Receivables Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 0.00 156,783,095.00 156,783,095.00 19,364,900,000.00 25,069,300,000.00 13,223,700,000.00 79,016,500,000.00 773,100,000.00 13,223,700,000.00 3,420,400,000.00 57,367,600,000.00 68,796,200,000.00 57,367,600,000.00 57,367,600,000.00 57,054,000,000.00 0.00 0.00 313,600,000.00 313,600,000.00 44,436,900,000.00 23,765,600,000.00 4,290,600,000.00 0.00 0.00 15,500,000.00 14,468,100,000.00 3,039,500,000.00 11,428,600,000.00 4,991,400,000.00 20,671,300,000.00 4,866,800,000.00 0.00 10,601,200,000.00 380,900,000.00 10,220,300,000.00 0.00 208,800,000.00 2,264,000,000.00 0.00 0.00 182,800,000.00 2,081,200,000.00 101,804,500,000.00 80,360,100,000.00 271,900,000.00 0.00 67,400,000.00 1,023,500,000.00 0.00 1,023,500,000.00 0.00 0.00 43,300,000.00 44,143,900,000.00 2,743,600,000.00 41,400,300,000.00 33,202,200,000.00 0.00 33,202,200,000.00 5,801,500,000.00 27,400,700,000.00 0.00 0.00 0.00 0.00 21,444,400,000.00 1,000,200,000.00 0.00 0.00 9,039,000,000.00 0.00 0.00 0.00 38,900,000.00 7,061,400,000.00 0.00 0.00 4,304,900,000.00 2,020,900,000.00 2,284,000,000.00 0.00 0.00
2024-03-31T00:00:00 quarterly 0.00 156,783,095.00 156,783,095.00 16,979,300,000.00 23,126,000,000.00 14,936,900,000.00 75,895,200,000.00 -6,265,300,000.00 14,936,900,000.00 3,505,800,000.00 56,275,000,000.00 58,707,300,000.00 56,275,000,000.00 56,275,000,000.00 5,596,140,000,000.00 1,740,900,000.00 47,396,800,000.00 313,600,000.00 313,600,000.00 39,539,100,000.00 13,991,900,000.00 448,680,000,000.00 22,400,000.00 4,463,800,000.00 393,300,000.00 5,322,000,000.00 2,889,700,000.00 2,432,300,000.00 3,790,400,000.00 25,547,200,000.00 693,600,000.00 0.00 17,804,000,000.00 616,100,000.00 17,187,900,000.00 1,471,400,000.00 315,000,000.00 3,084,500,000.00 334,800,000.00 300,000.00 308,200,000.00 2,441,200,000.00 95,814,100,000.00 76,532,200,000.00 100,000.00 1,225,400,000.00 107,900,000.00 788,500,000.00 0.00 788,500,000.00 0.00 0.00 43,200,000.00 41,338,100,000.00 2,231,400,000.00 39,106,700,000.00 32,361,400,000.00 -27,319,800,000.00 59,681,200,000.00 5,049,700,000.00 10,304,300,000.00 23,997,200,000.00 16,285,100,000.00 4,044,900,000.00 0.00 19,281,900,000.00 130,700,000,000.00 65,600,000.00 1,074,600,000.00 8,828,900,000.00 2,123,200,000.00 2,723,500,000.00 3,982,200,000.00 387,300,000.00 4,611,100,000.00 -111,800,000.00 4,722,900,000.00 4,314,400,000.00 1,673,500,000.00 2,640,900,000.00 25,600,000.00 2,615,300,000.00
2024-03-31T00:00:00 annual 0.00 156,783,095.00 156,783,095.00 16,979,300,000.00 23,126,000,000.00 14,936,900,000.00 75,895,200,000.00 -6,265,300,000.00 14,936,900,000.00 3,505,800,000.00 56,275,000,000.00 58,707,300,000.00 56,275,000,000.00 56,275,000,000.00 5,596,140,000,000.00 1,740,900,000.00 47,396,800,000.00 313,600,000.00 313,600,000.00 39,539,100,000.00 13,991,900,000.00 448,680,000,000.00 22,400,000.00 4,463,800,000.00 393,300,000.00 5,322,000,000.00 2,889,700,000.00 2,432,300,000.00 3,790,400,000.00 25,547,200,000.00 693,600,000.00 0.00 17,804,000,000.00 616,100,000.00 17,187,900,000.00 1,471,400,000.00 315,000,000.00 3,084,500,000.00 334,800,000.00 300,000.00 308,200,000.00 2,441,200,000.00 95,814,100,000.00 76,532,200,000.00 100,000.00 1,225,400,000.00 107,900,000.00 788,500,000.00 0.00 788,500,000.00 0.00 0.00 43,200,000.00 41,338,100,000.00 2,231,400,000.00 39,106,700,000.00 32,361,400,000.00 -27,319,800,000.00 59,681,200,000.00 5,049,700,000.00 10,304,300,000.00 23,997,200,000.00 16,285,100,000.00 4,044,900,000.00 0.00 19,281,900,000.00 130,700,000,000.00 65,600,000.00 1,074,600,000.00 8,828,900,000.00 2,123,200,000.00 2,723,500,000.00 3,982,200,000.00 387,300,000.00 4,611,100,000.00 -111,800,000.00 4,722,900,000.00 4,314,400,000.00 1,673,500,000.00 2,640,900,000.00 25,600,000.00 2,615,300,000.00
2023-09-30T00:00:00 quarterly 0.00 156,783,095.00 156,783,095.00 17,631,600,000.00 23,079,500,000.00 17,419,500,000.00 77,214,300,000.00 807,900,000.00 17,419,500,000.00 3,573,500,000.00 57,708,300,000.00 68,168,000,000.00 57,708,300,000.00 57,708,300,000.00 57,394,700,000.00 0.00 0.00 313,600,000.00 313,600,000.00 37,302,900,000.00 18,479,700,000.00 1,694,800,000.00 0.00 0.00 608,900,000.00 13,636,600,000.00 3,176,900,000.00 10,459,700,000.00 2,523,300,000.00 18,823,200,000.00 5,308,700,000.00 0.00 9,442,900,000.00 396,600,000.00 9,046,300,000.00 0.00 444,000,000.00 2,112,100,000.00 0.00 0.00 17,500,000.00 2,094,600,000.00 95,011,200,000.00 75,380,100,000.00 22,700,000.00 0.00 80,000,000.00 922,700,000.00 0.00 922,700,000.00 0.00 0.00 43,500,000.00 40,288,800,000.00 1,626,100,000.00 38,662,700,000.00 32,397,900,000.00 0.00 32,397,900,000.00 9,086,100,000.00 23,311,800,000.00 0.00 0.00 0.00 0.00 19,631,100,000.00 1,518,200,000.00 0.00 0.00 8,516,900,000.00 0.00 0.00 0.00 30,100,000.00 4,720,200,000.00 0.00 0.00 4,845,700,000.00 2,971,300,000.00 1,874,400,000.00 0.00 0.00
2023-03-31T00:00:00 quarterly 0.00 156,783,095.00 156,783,095.00 16,892,900,000.00 22,088,500,000.00 18,103,700,000.00 76,307,500,000.00 1,199,700,000.00 18,103,700,000.00 3,877,700,000.00 58,096,700,000.00 68,528,900,000.00 58,096,700,000.00 58,096,700,000.00 57,783,100,000.00 4,445,600,000.00 47,396,800,000.00 313,600,000.00 313,600,000.00 36,438,300,000.00 18,454,400,000.00 268,000,000.00 18,900,000.00 1,651,200,000.00 749,200,000.00 13,703,500,000.00 3,271,300,000.00 10,432,200,000.00 2,331,600,000.00 17,983,900,000.00 567,000,000.00 0.00 8,385,000,000.00 606,400,000.00 7,778,600,000.00 1,416,100,000.00 525,100,000.00 2,775,000,000.00 396,300,000.00 600,000.00 180,800,000.00 2,197,300,000.00 94,535,000,000.00 75,351,400,000.00 9,100,000.00 1,428,900,000.00 140,100,000.00 721,000,000.00 0.00 679,900,000.00 0.00 41,100,000.00 45,600,000.00 39,993,000,000.00 1,355,400,000.00 38,637,600,000.00 32,347,000,000.00 -24,794,100,000.00 57,141,100,000.00 10,038,500,000.00 9,397,300,000.00 20,450,000,000.00 13,227,000,000.00 4,028,300,000.00 0.00 19,183,600,000.00 1,489,200,000.00 121,000,000.00 1,002,700,000.00 8,038,000,000.00 2,163,600,000.00 2,642,900,000.00 3,231,500,000.00 540,700,000.00 5,899,100,000.00 -22,900,000.00 5,922,000,000.00 3,582,100,000.00 2,264,200,000.00 1,317,900,000.00 600,000.00 1,317,300,000.00
2023-03-31T00:00:00 annual 0.00 156,783,095.00 156,783,095.00 16,892,900,000.00 22,088,500,000.00 18,103,700,000.00 76,307,500,000.00 1,199,700,000.00 18,103,700,000.00 3,877,700,000.00 58,096,700,000.00 68,528,900,000.00 58,096,700,000.00 58,096,700,000.00 57,783,100,000.00 4,445,600,000.00 47,396,800,000.00 313,600,000.00 313,600,000.00 36,438,300,000.00 18,454,400,000.00 268,000,000.00 18,900,000.00 1,651,200,000.00 749,200,000.00 13,703,500,000.00 3,271,300,000.00 10,432,200,000.00 2,331,600,000.00 17,983,900,000.00 567,000,000.00 0.00 8,385,000,000.00 606,400,000.00 7,778,600,000.00 1,416,100,000.00 525,100,000.00 2,775,000,000.00 396,300,000.00 600,000.00 180,800,000.00 2,197,300,000.00 94,535,000,000.00 75,351,400,000.00 9,100,000.00 1,428,900,000.00 140,100,000.00 721,000,000.00 0.00 679,900,000.00 0.00 41,100,000.00 45,600,000.00 39,993,000,000.00 1,355,400,000.00 38,637,600,000.00 32,347,000,000.00 -24,794,100,000.00 57,141,100,000.00 10,038,500,000.00 9,397,300,000.00 20,450,000,000.00 13,227,000,000.00 4,028,300,000.00 0.00 19,183,600,000.00 1,489,200,000.00 121,000,000.00 1,002,700,000.00 8,038,000,000.00 2,163,600,000.00 2,642,900,000.00 3,231,500,000.00 540,700,000.00 5,899,100,000.00 -22,900,000.00 5,922,000,000.00 3,582,100,000.00 2,264,200,000.00 1,317,900,000.00 600,000.00 1,317,300,000.00
2022-03-31T00:00:00 annual 4,611,177.00 156,783,095.00 156,783,095.00 13,100,900,000.00 18,298,900,000.00 17,881,700,000.00 69,692,700,000.00 4,189,300,000.00 17,881,700,000.00 4,095,600,000.00 55,489,400,000.00 63,104,400,000.00 55,489,400,000.00 55,489,400,000.00 55,175,800,000.00 4,231,300,000.00 47,396,800,000.00 313,600,000.00 313,600,000.00 30,885,100,000.00 16,687,200,000.00 1,529,100,000.00 264,100,000.00 1,265,000,000.00 1,285,600,000.00 11,101,600,000.00 3,486,600,000.00 7,615,000,000.00 2,770,900,000.00 14,197,900,000.00 432,700,000.00 0.00 7,197,300,000.00 609,000,000.00 6,588,300,000.00 1,193,400,000.00 302,200,000.00 2,081,500,000.00 0.00 700,000.00 147,100,000.00 1,933,700,000.00 86,374,500,000.00 67,987,300,000.00 81,100,000.00 1,424,700,000.00 32,500,000.00 318,300,000.00 0.00 318,300,000.00 0.00 0.00 45,600,000.00 37,607,700,000.00 1,150,900,000.00 36,456,800,000.00 27,898,500,000.00 -21,311,600,000.00 49,210,100,000.00 7,577,900,000.00 8,740,900,000.00 17,702,400,000.00 11,281,200,000.00 3,907,700,000.00 0.00 18,387,200,000.00 1,799,000,000.00 127,700,000.00 1,027,000,000.00 6,451,200,000.00 1,501,900,000.00 2,168,800,000.00 2,780,500,000.00 1,503,700,000.00 4,734,200,000.00 -24,900,000.00 4,759,100,000.00 4,543,400,000.00 3,441,000,000.00 1,102,400,000.00 500,000.00 1,101,900,000.00
2021-03-31T00:00:00 annual 4,611,177.00 156,783,095.00 156,783,095.00 9,219,500,000.00 15,888,500,000.00 19,611,600,000.00 68,643,100,000.00 4,138,500,000.00 19,611,600,000.00 4,233,600,000.00 56,988,200,000.00 62,023,600,000.00 56,988,200,000.00 56,988,200,000.00 0.00 3,506,900,000.00 47,396,800,000.00 313,600,000.00 313,600,000.00 26,672,800,000.00 13,769,900,000.00 100,000.00 51,400,000.00 0.00 1,917,700,000.00 8,690,800,000.00 3,655,400,000.00 5,035,400,000.00 3,109,900,000.00 12,902,900,000.00 267,800,000.00 0.00 7,197,700,000.00 578,200,000.00 6,619,500,000.00 1,037,000,000.00 100,800,000.00 1,865,000,000.00 29,700,000.00 900,000.00 142,100,000.00 1,692,300,000.00 83,661,000,000.00 66,619,600,000.00 2,039,600,000.00 1,374,400,000.00 102,400,000.00 557,800,000.00 45,100,000.00 557,800,000.00 100,000.00 0.00 49,400,000.00 37,376,600,000.00 1,566,500,000.00 35,810,100,000.00 26,280,900,000.00 -18,304,300,000.00 44,585,200,000.00 6,112,700,000.00 7,268,800,000.00 17,125,300,000.00 10,326,900,000.00 3,751,500,000.00 0.00 17,041,400,000.00 2,321,900,000.00 139,700,000.00 661,400,000.00 5,156,500,000.00 1,838,100,000.00 1,701,800,000.00 1,616,600,000.00 2,362,400,000.00 4,207,100,000.00 -72,600,000.00 4,279,700,000.00 4,514,300,000.00 2,078,900,000.00 2,435,400,000.00 0.00 2,435,400,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23,600,000.00 0.00 0.00 0.00 0.00 0.00 0.00 409,500,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 296,200,000.00 0.00 31,700,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: DCAL Cash Flow Data In (Cr)

date period_type Free Cash Flow Repurchase Of Capital Stock Repayment Of Debt Issuance Of Debt Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Effect Of Exchange Rate Changes Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Cash Dividends Paid Common Stock Dividend Paid Net Common Stock Issuance Common Stock Payments Net Issuance Payments Of Debt Net Short Term Debt Issuance Net Long Term Debt Issuance Long Term Debt Payments Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Dividends Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Assets Change In Payable Change In Inventory Change In Receivables Other Non Cash Items Provisionand Write Offof Assets Depreciation And Amortization Amortization Cash Flow Depreciation Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual 807,200,000.00 0.00 -978,000,000.00 1,482,400,000.00 -3,032,500,000.00 2,640,900,000.00 0.00 1,317,900,000.00 0.00 1,323,000,000.00 -221,500,000.00 0.00 -986,300,000.00 0.00 0.00 0.00 0.00 1,192,600,000.00 688,200,000.00 504,400,000.00 -978,000,000.00 1,482,400,000.00 -2,295,200,000.00 0.00 121,300,000.00 0.00 614,700,000.00 1,498,900,000.00 -884,200,000.00 -3,031,200,000.00 1,300,000.00 -3,032,500,000.00 3,839,700,000.00 -189,700,000.00 1,438,300,000.00 174,900,000.00 880,900,000.00 -852,400,000.00 1,234,900,000.00 1,117,200,000.00 0.00 3,108,600,000.00 587,500,000.00 2,521,100,000.00 -19,100,000.00 -542,200,000.00 53,900,000.00 -1,222,600,000.00
2023-03-31T00:00:00 annual -3,537,300,000.00 0.00 -1,656,800,000.00 3,321,900,000.00 -6,196,800,000.00 1,317,900,000.00 100,000.00 1,102,400,000.00 0.00 215,400,000.00 2,496,700,000.00 0.00 -732,800,000.00 0.00 0.00 0.00 0.00 3,549,100,000.00 1,884,000,000.00 1,665,100,000.00 -1,656,800,000.00 3,321,900,000.00 -4,940,800,000.00 52,700,000.00 156,000,000.00 0.00 1,088,100,000.00 1,211,500,000.00 -123,400,000.00 -6,182,000,000.00 14,800,000.00 -6,196,800,000.00 2,659,500,000.00 -341,800,000.00 -377,300,000.00 325,100,000.00 2,080,800,000.00 -1,586,800,000.00 -1,196,400,000.00 1,088,600,000.00 -2,000,000.00 2,807,200,000.00 631,800,000.00 2,175,400,000.00 -3,200,000.00 -4,600,000.00 35,700,000.00 -545,900,000.00
2022-03-31T00:00:00 annual -1,089,500,000.00 0.00 -1,666,700,000.00 4,486,700,000.00 -4,638,000,000.00 1,102,400,000.00 100,000.00 2,435,400,000.00 0.00 -1,333,100,000.00 1,303,700,000.00 0.00 -597,900,000.00 0.00 0.00 0.00 0.00 2,168,200,000.00 -651,800,000.00 2,820,000,000.00 -1,666,700,000.00 4,486,700,000.00 -6,185,300,000.00 -218,300,000.00 271,200,000.00 0.00 -1,711,500,000.00 0.00 -1,711,500,000.00 -4,554,700,000.00 83,300,000.00 -4,638,000,000.00 3,548,500,000.00 -563,300,000.00 900,800,000.00 570,300,000.00 2,357,100,000.00 -1,433,000,000.00 -593,600,000.00 290,000,000.00 -52,300,000.00 3,075,900,000.00 1,005,500,000.00 2,070,400,000.00 -47,700,000.00 25,600,000.00 19,300,000.00 -42,500,000.00
2021-03-31T00:00:00 annual 1,466,300,000.00 -23,100,000.00 -1,869,700,000.00 3,562,000,000.00 -3,660,300,000.00 2,435,400,000.00 0.00 1,219,400,000.00 0.00 1,216,000,000.00 -110,400,000.00 0.00 -528,500,000.00 0.00 0.00 -23,100,000.00 -23,100,000.00 1,024,600,000.00 -667,700,000.00 1,692,300,000.00 -1,869,700,000.00 3,562,000,000.00 -3,800,200,000.00 -209,900,000.00 408,300,000.00 0.00 208,200,000.00 0.00 -91,800,000.00 -3,652,600,000.00 7,700,000.00 -3,660,300,000.00 5,126,600,000.00 -512,000,000.00 3,163,500,000.00 850,200,000.00 -399,500,000.00 909,100,000.00 1,803,700,000.00 258,400,000.00 -22,200,000.00 3,079,400,000.00 1,033,800,000.00 2,045,600,000.00 -23,400,000.00 -215,500,000.00 -1,800,000.00 -650,300,000.00
2020-03-31T00:00:00 annual 0.00 -366,500,000.00 0.00 0.00 0.00 0.00 -100,000.00 0.00 0.00 0.00 0.00 100,000.00 0.00 -32,300,000.00 -32,300,000.00 -366,500,000.00 -366,500,000.00 0.00 0.00 0.00 0.00 0.00 0.00 -243,300,000.00 0.00 0.00 0.00 606,200,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: DCAL Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Minority Interests Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Write Off Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual -2.45 0.00 311.63 -9.62 -9.62 -153.45 310.86 611.61 302.01 -8.85 -105.58 113.41 13.00 -146.28 -153.45 2,552.10 10.01 15.68 15.68 0.00 0.00 -153.45 -153.45 0.00 -153.45 0.00 -153.45 -153.45 31.19 -122.26 13.30 -11.53 11.53 0.00 -105.58 5.17 113.41 13.00 -8.48 1,940.49 337.56 310.86 58.75 252.11 139.22 24.80 114.42 10.01 1,932.01 611.61 2,543.62 2,543.62
2023-03-31T00:00:00 annual -15.42 0.00 351.92 -51.40 -51.40 -29.80 280.72 534.21 300.52 19.80 -63.24 74.39 18.25 6.18 -29.80 2,209.56 8.76 15.68 15.68 0.00 0.00 -29.80 -29.80 0.00 -29.80 0.00 -29.80 -29.80 -24.79 -54.59 9.20 -51.72 51.72 0.00 -63.24 7.10 74.39 18.25 105.49 1,675.35 310.84 280.72 63.18 217.54 135.81 35.47 100.34 8.76 1,780.84 534.21 2,315.05 2,315.05
2022-03-31T00:00:00 annual -3.54 0.00 354.36 -11.80 -11.80 18.01 307.59 458.88 342.56 34.97 -29.00 39.22 19.15 26.27 18.01 2,110.83 8.49 15.68 15.68 0.00 0.00 18.01 18.01 0.00 18.01 0.00 18.01 18.01 -22.26 -4.25 19.50 -16.57 16.57 0.00 -29.00 8.93 39.22 19.15 29.85 1,651.95 245.83 307.59 100.55 207.04 101.60 29.44 72.16 8.49 1,681.80 458.88 2,140.68 2,140.68
2021-03-31T00:00:00 annual -7.44 0.00 306.75 -24.81 -24.81 -165.13 307.94 484.09 281.94 -26.00 -21.74 39.03 21.77 -147.76 -165.13 1,924.38 6.54 15.68 15.68 0.00 0.00 -165.13 -165.13 0.00 -165.13 0.00 -165.13 -165.13 100.10 -65.03 14.16 -27.15 22.10 5.05 -21.74 4.48 39.03 21.77 -12.35 1,440.29 164.71 307.94 103.38 204.56 85.03 21.94 63.09 6.54 1,427.94 484.09 1,912.03 1,912.03
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
5/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

-11.12

P/E

N/A

P/B

0.7380941

Dividend Yield

N/A

Market Cap

4,234.38 Cr.

Face Value

365.807

Book Value

365.807

ROE

-6.66%

EBITDA Growth

231.60 Cr.

Debt/Equity

43.699

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

DCAL News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

DCAL News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

DCAL News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

DCAL News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

DCAL News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

DCAL News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

DCAL News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

DCAL News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy dcal Shares on Fincept?

You can buy Dishman Carbogen Amcis Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of dcal?

The market capitalization of Dishman Carbogen Amcis Limited is ₹4,234 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Dishman Carbogen Amcis Limited?

The PE and PB ratios of Dishman Carbogen Amcis Limited are Not Available and 0.7380941 respectively as of 05 Feb 2025.

What is the 52 Week High of Dishman Carbogen Amcis Limited?

The 52-week high of Dishman Carbogen Amcis Limited is ₹307.98 as of 05 Feb 2025.

What is the 52 Week Low of Dishman Carbogen Amcis Limited?

The 52-week low of Dishman Carbogen Amcis Limited is ₹133 as of 05 Feb 2025.

What are the earnings per share (EPS) for Dishman Carbogen Amcis Limited?

The Earnings Per Share (EPS) of Dishman Carbogen Amcis Limited is ₹-11.12 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Dishman Carbogen Amcis Limited?

The Return on Equity (ROE) of Dishman Carbogen Amcis Limited is -6.66% as per the most recent financial year data. Explore more on Fincept.

ORTEL

View Stock

VISHNU

View Stock

SUMICHEM

View Stock

CLSEL

View Stock

SURAJEST

View Stock

GRPLTD

View Stock

PANACEABIO

View Stock

NOVAAGRI

View Stock

GENSOL

View Stock

SCHAEFFLER

View Stock

ORIENTHOT

View Stock

VSTTILLERS

View Stock